Invesco Exchange-Traded Fund Trust II (IBBQ)
Management Company · XNAS · Series S000072469 · View on SEC EDGAR ↗
$29.56
As of March 10, 2026
▲ +0.20 (+0.67%)
1-day change
$17.84 – $30.49
52-week range
Net flows (30d): +$3.3M Estimated from creation/redemption of shares outstanding
- Net assets
- $67.4M
- Holdings
- 261
- As of
- May 31, 2026
- Top 10 holdings weight
- 56.58%
- Effective number of positions
- 20.2
- Positions above 1%
- 27
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Recent changes Positions the fund added, trimmed or exited most recently.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
IBBQ Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of March 10, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +0.85% | — |
| 3M | ▲ +4.28% | — |
| 6M | ▲ +24.21% | — |
| YTD | ▲ +4.10% | — |
| 1Y | ▲ +32.08% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Feb. 27, 2024 | ▲ +28.63% | — |
- Volatility 1Y
- 22.75%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 1.35
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (May 2026)
- +$0
- Quarter ending May 2026
- -$7.6M
- Trailing 12 months
- +$15.2M
Jun 2025 – May 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 261 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Invesco Private Prime Fund | — | $9.6M | 14.20 | 9,567,964 | STIV | US |
| Gilead Sciences, Inc. | 375558103 | $5.0M | 7.39 | 37,039 | EC | US |
| Vertex Pharmaceuticals Inc. | 92532F100 | $5.0M | 7.38 | 11,104 | EC | US |
| Amgen Inc. | 031162100 | $4.8M | 7.10 | 14,213 | EC | US |
| Invesco Private Government Fund | — | $3.7M | 5.48 | 3,691,132 | STIV | US |
| Regeneron Pharmaceuticals, Inc. | 75886F107 | $3.4M | 5.08 | 5,570 | EC | US |
| Alnylam Pharmaceuticals, Inc. | 02043Q107 | $2.1M | 3.19 | 7,110 | EC | US |
| Revolution Medicines, Inc. | 76155X100 | $1.7M | 2.48 | 10,624 | EC | US |
| Biogen Inc. | 09062X103 | $1.5M | 2.29 | 7,868 | EC | US |
| Illumina, Inc. | 452327109 | $1.3M | 1.98 | 8,197 | EC | US |
| United Therapeutics Corp. | 91307C102 | $1.3M | 1.94 | 2,350 | EC | US |
| Royalty Pharma PLC | G7709Q104 | $1.3M | 1.90 | 22,968 | EC | GB |
| argenx SE | 04016X101 | $1.3M | 1.89 | 1,521 | EC | NL |
| Insmed Inc. | 457669307 | $1.2M | 1.83 | 11,556 | EC | US |
| Roivant Sciences Ltd. | G76279101 | $1.2M | 1.71 | 38,370 | EC | BM |
| Incyte Corp. | 45337C102 | $1.0M | 1.53 | 10,669 | EC | US |
| Viatris Inc. | 92556V106 | $1.0M | 1.49 | 61,728 | EC | US |
| Moderna, Inc. | 60770K107 | $999K | 1.48 | 21,173 | EC | US |
| Guardant Health, Inc. | 40131M109 | $912K | 1.35 | 7,032 | EC | US |
| Neurocrine Biosciences, Inc. | 64125C109 | $852K | 1.26 | 5,381 | EC | US |
| Jazz Pharmaceuticals PLC | G50871105 | $780K | 1.16 | 3,300 | EC | IE |
| Ascendis Pharma A/S | K08588103 | $740K | 1.10 | 3,301 | EC | DK |
| Summit Therapeutics Inc. | 86627T108 | $729K | 1.08 | 41,569 | EC | US |
| Exelixis, Inc. | 30161Q104 | $703K | 1.04 | 13,923 | EC | US |
| BridgeBio Pharma, Inc. | 10806X102 | $689K | 1.02 | 10,393 | EC | US |
| Medpace Holdings, Inc. | 58506Q109 | $681K | 1.01 | 1,522 | EC | US |
| Ionis Pharmaceuticals, Inc. | 462222100 | $677K | 1.01 | 8,856 | EC | US |
| Axsome Therapeutics, Inc. | 05464T104 | $643K | 0.95 | 2,742 | EC | US |
| Madrigal Pharmaceuticals, Inc. | 558868105 | $612K | 0.91 | 1,230 | EC | US |
| BioMarin Pharmaceutical Inc. | 09061G101 | $591K | 0.88 | 10,311 | EC | US |
| BioNTech SE | 09075V102 | $586K | 0.87 | 6,112 | EC | DE |
| Arrowhead Pharmaceuticals, Inc. | 04280A100 | $585K | 0.87 | 7,507 | EC | US |
| Sanofi | 80105N105 | $573K | 0.85 | 13,122 | EC | FR |
| Praxis Precision Medicines, Inc. | 74006W207 | $523K | 0.78 | 1,493 | EC | US |
| Cytokinetics, Inc. | 23282W605 | $506K | 0.75 | 6,597 | EC | US |
| BeOne Medicines Ltd. | 07725L102 | $493K | 0.73 | 1,714 | EC | CH |
| Krystal Biotech, Inc. | 501147102 | $484K | 0.72 | 1,567 | EC | US |
| Tempus AI, Inc. | 88023B103 | $470K | 0.70 | 9,314 | EC | US |
| Abivax S.A. | 00370M103 | $437K | 0.65 | 3,294 | EC | FR |
| Nuvalent, Inc. | 670703107 | $433K | 0.64 | 3,923 | EC | US |
| Halozyme Therapeutics, Inc. | 40637H109 | $421K | 0.62 | 6,327 | EC | US |
| ImmunityBio, Inc. | 45256X103 | $414K | 0.62 | 55,119 | EC | US |
| Vaxcyte, Inc. | 92243G108 | $397K | 0.59 | 7,716 | EC | US |
| Alkermes PLC | G01767105 | $377K | 0.56 | 8,934 | EC | IE |
| Immunovant, Inc. | 45258J102 | $363K | 0.54 | 10,912 | EC | US |
| Kymera Therapeutics, Inc. | 501575104 | $356K | 0.53 | 4,377 | EC | US |
| Protagonist Therapeutics, Inc. | 74366E102 | $341K | 0.51 | 3,421 | EC | US |
| Mirum Pharmaceuticals, Inc. | 604749101 | $328K | 0.49 | 3,235 | EC | US |
| PTC Therapeutics, Inc. | 69366J200 | $327K | 0.49 | 4,433 | EC | US |
| Rhythm Pharmaceuticals, Inc. | 76243J105 | $323K | 0.48 | 3,661 | EC | US |
Page 1
of 6
← Previous
Next →
Sector breakdown
Healthcare
82.4%
Other/Unmapped
17.6%
Daily changes (30d)
| Date | Type | Ticker | Change |
|---|---|---|---|
| Aug. 14, 2026 | Trimmed |
2200963D — OmniAb Inc
68218J202
|
Units/share: 0.00005274 → 0.00005187 (-1.7%) |
| Aug. 14, 2026 | Trimmed |
2200964D — OmniAb Inc
68218J301
|
Units/share: 0.00005274 → 0.00005187 (-1.7%) |
| Aug. 14, 2026 | Trimmed |
2324462D — Cartesian Therapeutics Inc
816212112
|
Units/share: 0.001111 → 0.001093 (-1.7%) |
| Aug. 14, 2026 | Trimmed |
2600057D — Novo Nordisk A/S
009CVR108
|
Units/share: 0.001601 → 0.001574 (-1.7%) |
| Aug. 14, 2026 | Trimmed |
2645588D — Eli Lilly & Co
152CVR015
|
Units/share: 0.002677 → 0.002632 (-1.7%) |
| Aug. 14, 2026 | Trimmed |
2673120D — Esperion Therapeutics Inc
296CVR020
|
Units/share: 0.00558 → 0.005488 (-1.7%) |
| Aug. 14, 2026 | Increased |
AGIO — Agios Pharmaceuticals Inc
00847X104
|
Units/share: 0.001366 → 0.001367 (0.1%) |
| Aug. 14, 2026 | Trimmed |
AGPXX — Invesco Government & Agency Portfolio
825252885
|
Units/share: 0.01913 → 0.01535 (-19.8%) |
| Aug. 14, 2026 | Trimmed |
ARCT — Arcturus Therapeutics Holdings Inc
03969T109
|
Units/share: 0.0006439 → 0.0006432 (-0.1%) |
| Aug. 14, 2026 | Increased |
AVBP — ArriVent Biopharma Inc
04272N102
|
Units/share: 0.001069 → 0.001071 (0.1%) |
| Aug. 14, 2026 | Increased |
BCYC — Bicycle Therapeutics PLC
088786108
|
Units/share: 0.001061 → 0.001062 (0.2%) |
| Aug. 14, 2026 | Increased |
CTNM — Contineum Therapeutics Inc
21217B100
|
Units/share: 0.0007527 → 0.0007535 (0.1%) |
| Aug. 14, 2026 | Trimmed |
FHTX — Foghorn Therapeutics Inc
344174107
|
Units/share: 0.001334 → 0.001332 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
GMAB — Genmab A/S
372303206
|
Units/share: 0.001742 → 0.001741 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
INBX — Inhibrx Biosciences Inc
45720N103
|
Units/share: 0.0003359 → 0.0003353 (-0.2%) |
| Aug. 14, 2026 | Increased |
IRON — Disc Medicine Inc
254604101
|
Units/share: 0.0008771 → 0.000878 (0.1%) |
| Aug. 14, 2026 | Trimmed |
JAZZ — Jazz Pharmaceuticals PLC
G50871105
|
Units/share: 0.001441 → 0.001439 (-0.1%) |
| Aug. 14, 2026 | Increased |
KNSA — Kiniksa Pharmaceuticals International Plc
G52694109
|
Units/share: 0.001063 → 0.001065 (0.1%) |
| Aug. 14, 2026 | Trimmed |
KOD — Kodiak Sciences Inc
50015M109
|
Units/share: 0.001437 → 0.001435 (-0.1%) |
| Aug. 14, 2026 | Increased |
KROS — Keros Therapeutics Inc
492327101
|
Units/share: 0.0004532 → 0.0004539 (0.2%) |
| Aug. 14, 2026 | Increased |
KRYS — Krystal Biotech Inc
501147102
|
Units/share: 0.0006771 → 0.000678 (0.1%) |
| Aug. 14, 2026 | Increased |
LGND — Ligand Pharmaceuticals Inc
53220K504
|
Units/share: 0.0004612 → 0.0004618 (0.1%) |
| Aug. 14, 2026 | Trimmed |
LKFT — Lakefront Biotherapeutics NV
36315X101
|
Units/share: 0.0003439 → 0.0003432 (-0.2%) |
| Aug. 14, 2026 | Increased |
MEDP — Medpace Holdings Inc
58506Q109
|
Units/share: 0.000657 → 0.0006577 (0.1%) |
| Aug. 14, 2026 | Increased |
NGNE — Neurogene Inc
64135M105
|
Units/share: 0.0003608 → 0.0003614 (0.2%) |
| Aug. 14, 2026 | Increased |
OBIO — Orchestra BioMed Holdings Inc
68572M106
|
Units/share: 0.001362 → 0.001363 (0.1%) |
| Aug. 14, 2026 | Increased |
PAHC — Phibro Animal Health Corp
71742Q106
|
Units/share: 0.000484 → 0.0004846 (0.1%) |
| Aug. 14, 2026 | Increased |
PBYI — Puma Biotechnology Inc
74587V107
|
Units/share: 0.001158 → 0.001159 (0.2%) |
| Aug. 14, 2026 | Trimmed |
PRAX — Praxis Precision Medicines Inc
74006W207
|
Units/share: 0.0006392 → 0.0006386 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
PYXS — Pyxis Oncology Inc
747324101
|
Units/share: 0.001439 → 0.001437 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
QURE — uniQure NV
N90064101
|
Units/share: 0.001448 → 0.001446 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
SEPN — Septerna Inc
81734D104
|
Units/share: 0.001035 → 0.001034 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
SION — Sionna Therapeutics Inc
829401108
|
Units/share: 0.001037 → 0.001035 (-0.1%) |
| Aug. 14, 2026 | Increased |
SLN — Silence Therapeutics PLC
82686Q101
|
Units/share: 0.001068 → 0.001069 (0.1%) |
| Aug. 14, 2026 | Trimmed |
SUPN — Supernus Pharmaceuticals Inc
868459108
|
Units/share: 0.001333 → 0.001332 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
TECX — Tectonic Therapeutic Inc
878972108
|
Units/share: 0.0004325 → 0.000432 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
THRD — Third Harmonic Bio Inc
88427A107
|
Units/share: 0.0006772 → 0.000666 (-1.7%) |
| Aug. 14, 2026 | Increased |
TYRA — Tyra Biosciences Inc
90240B106
|
Units/share: 0.001366 → 0.001367 (0.1%) |
| Aug. 14, 2026 | Trimmed |
UPB — Upstream Bio Inc
91678A107
|
Units/share: 0.001236 → 0.001234 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
USD — CASH & EQUIVALENTS
CASHUSD00
|
Units/share: 0.003636 → 0.003576 (-1.7%) |
| Aug. 14, 2026 | Increased |
UTHR — United Therapeutics Corp
91307C102
|
Units/share: 0.0009749 → 0.0009759 (0.1%) |
| Aug. 14, 2026 | Trimmed |
VERA — Vera Therapeutics Inc
92337R101
|
Units/share: 0.001648 → 0.001646 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
VOR — Vor BioPharma Inc
929033207
|
Units/share: 0.001244 → 0.001242 (-0.1%) |
| Aug. 14, 2026 | Trimmed |
ZBIO — Zenas Biopharma Inc
98937L105
|
Units/share: 0.00145 → 0.001448 (-0.1%) |
| Aug. 14, 2026 | Increased |
ZVRA — Zevra Therapeutics Inc
488445206
|
Units/share: 0.001358 → 0.001359 (0.1%) |
| Aug. 14, 2026 | Trimmed |
— SECURITIES LENDING - BNYM
BNYMLEND
|
Units/share: 0.0000004219 → 0.0000004149 (-1.7%) |
| Aug. 10, 2026 | Exited |
9666679D
Y95308105
|
Position exited — was 0.004418 units/share |
| Aug. 10, 2026 | New |
WVE — Wave Life Sciences Inc
94352A104
|
New position — 0.004418 units/share |
| Aug. 4, 2026 | Trimmed |
2200963D — OmniAb Inc
68218J202
|
Units/share: 0.00005342 → 0.00005274 (-1.3%) |
| Aug. 4, 2026 | Trimmed |
2200964D — OmniAb Inc
68218J301
|
Units/share: 0.00005342 → 0.00005274 (-1.3%) |
| Aug. 4, 2026 | Trimmed |
2324462D — Cartesian Therapeutics Inc
816212112
|
Units/share: 0.001125 → 0.001111 (-1.3%) |
| Aug. 4, 2026 | Trimmed |
2600057D — Novo Nordisk A/S
009CVR108
|
Units/share: 0.001621 → 0.001601 (-1.3%) |
| Aug. 4, 2026 | Trimmed |
2645588D — Eli Lilly & Co
152CVR015
|
Units/share: 0.002711 → 0.002677 (-1.3%) |
| Aug. 4, 2026 | Trimmed |
2673120D — Esperion Therapeutics Inc
296CVR020
|
Units/share: 0.005652 → 0.00558 (-1.3%) |
| Aug. 4, 2026 | Trimmed |
AGPXX — Invesco Government & Agency Portfolio
825252885
|
Units/share: 0.01924 → 0.01913 (-0.6%) |
| Aug. 4, 2026 | Increased |
ANAB — AnaptysBio Inc
032724106
|
Units/share: 0.0006684 → 0.0006692 (0.1%) |
| Aug. 4, 2026 | Trimmed |
ANIP — ANI Pharmaceuticals Inc
00182C103
|
Units/share: 0.0005221 → 0.0005215 (-0.1%) |
| Aug. 4, 2026 | Trimmed |
ARCT — Arcturus Therapeutics Holdings Inc
03969T109
|
Units/share: 0.000645 → 0.0006439 (-0.2%) |
| Aug. 4, 2026 | Trimmed |
ARGX — Argenx SE
04016X101
|
Units/share: 0.0006338 → 0.0006329 (-0.1%) |
| Aug. 4, 2026 | Trimmed |
COLL — Collegium Pharmaceutical Inc
19459J104
|
Units/share: 0.0007446 → 0.0007435 (-0.2%) |
| Aug. 4, 2026 | Increased |
CTNM — Contineum Therapeutics Inc
21217B100
|
Units/share: 0.0007515 → 0.0007527 (0.2%) |
| Aug. 4, 2026 | Increased |
ENTA — Enanta Pharmaceuticals Inc
29251M106
|
Units/share: 0.0006615 → 0.0006624 (0.1%) |
| Aug. 4, 2026 | Trimmed |
ETON — Eton Pharmaceuticals Inc
29772L108
|
Units/share: 0.000629 → 0.0006283 (-0.1%) |
| Aug. 4, 2026 | Increased |
HROW — Harrow Inc
415858109
|
Units/share: 0.0008558 → 0.000857 (0.1%) |
| Aug. 4, 2026 | Trimmed |
INBX — Inhibrx Biosciences Inc
45720N103
|
Units/share: 0.0003363 → 0.0003359 (-0.1%) |
| Aug. 4, 2026 | Increased |
KROS — Keros Therapeutics Inc
492327101
|
Units/share: 0.0004526 → 0.0004532 (0.1%) |
| Aug. 4, 2026 | Increased |
LFCR — Lifecore Biomedical Inc
514766104
|
Units/share: 0.0008532 → 0.0008544 (0.1%) |
| Aug. 4, 2026 | Increased |
LGND — Ligand Pharmaceuticals Inc
53220K504
|
Units/share: 0.0004607 → 0.0004612 (0.1%) |
| Aug. 4, 2026 | Trimmed |
LKFT — Lakefront Biotherapeutics NV
36315X101
|
Units/share: 0.0003444 → 0.0003439 (-0.2%) |
| Aug. 4, 2026 | Trimmed |
LYEL — Lyell Immunopharma Inc
55083R203
|
Units/share: 0.0005294 → 0.0005287 (-0.1%) |
| Aug. 4, 2026 | Trimmed |
MDGL — Madrigal Pharmaceuticals Inc
558868105
|
Units/share: 0.0005294 → 0.0005287 (-0.1%) |
| Aug. 4, 2026 | Increased |
MEDP — Medpace Holdings Inc
58506Q109
|
Units/share: 0.0006558 → 0.000657 (0.2%) |
| Aug. 4, 2026 | Increased |
NGNE — Neurogene Inc
64135M105
|
Units/share: 0.0003603 → 0.0003608 (0.1%) |
| Aug. 4, 2026 | Increased |
ONC — BeOne Medicines Ltd
07725L102
|
Units/share: 0.0007584 → 0.0007595 (0.1%) |
| Aug. 4, 2026 | Trimmed |
PRAX — Praxis Precision Medicines Inc
74006W207
|
Units/share: 0.0006403 → 0.0006392 (-0.2%) |
| Aug. 4, 2026 | Trimmed |
RIGL — Rigel Pharmaceuticals Inc
766559702
|
Units/share: 0.0004247 → 0.0004241 (-0.1%) |
| Aug. 4, 2026 | Trimmed |
TECX — Tectonic Therapeutic Inc
878972108
|
Units/share: 0.0004333 → 0.0004325 (-0.2%) |
| Aug. 4, 2026 | Trimmed |
THRD — Third Harmonic Bio Inc
88427A107
|
Units/share: 0.0006859 → 0.0006772 (-1.3%) |
| Aug. 4, 2026 | Trimmed |
USD — CASH & EQUIVALENTS
CASHUSD00
|
Units/share: 0.003736 → 0.003636 (-2.7%) |
| Aug. 4, 2026 | Increased |
ZLAB — Zai Lab Ltd
98887Q104
|
Units/share: 0.0007563 → 0.0007574 (0.1%) |
| Aug. 4, 2026 | Trimmed |
— SECURITIES LENDING - BNYM
BNYMLEND
|
Units/share: 0.0000004274 → 0.0000004219 (-1.3%) |
| Aug. 3, 2026 | Increased |
USD — CASH & EQUIVALENTS
CASHUSD00
|
Units/share: 0.003683 → 0.003736 (1.5%) |
| July 23, 2026 | Trimmed |
2200963D — OmniAb Inc
68218J202
|
Units/share: 0.00005388 → 0.00005342 (-0.9%) |
| July 23, 2026 | Trimmed |
2200964D — OmniAb Inc
68218J301
|
Units/share: 0.00005388 → 0.00005342 (-0.9%) |
| July 23, 2026 | Trimmed |
2324462D — Cartesian Therapeutics Inc
816212112
|
Units/share: 0.001135 → 0.001125 (-0.9%) |
| July 23, 2026 | Trimmed |
2600057D — Novo Nordisk A/S
009CVR108
|
Units/share: 0.001635 → 0.001621 (-0.9%) |
| July 23, 2026 | Trimmed |
2645588D — Eli Lilly & Co
152CVR015
|
Units/share: 0.002734 → 0.002711 (-0.9%) |
| July 23, 2026 | Trimmed |
2673120D — Esperion Therapeutics Inc
296CVR020
|
Units/share: 0.0057 → 0.005652 (-0.9%) |
| July 23, 2026 | Trimmed |
AGPXX — Invesco Government & Agency Portfolio
825252885
|
Units/share: 0.01929 → 0.01924 (-0.3%) |
| July 23, 2026 | Trimmed |
INBX — Inhibrx Biosciences Inc
45720N103
|
Units/share: 0.0003368 → 0.0003363 (-0.1%) |
| July 23, 2026 | Increased |
KROS — Keros Therapeutics Inc
492327101
|
Units/share: 0.0004519 → 0.0004526 (0.1%) |
| July 23, 2026 | Increased |
LGND — Ligand Pharmaceuticals Inc
53220K504
|
Units/share: 0.0004602 → 0.0004607 (0.1%) |
| July 23, 2026 | Trimmed |
LKFT — Lakefront Biotherapeutics NV
36315X101
|
Units/share: 0.000345 → 0.0003444 (-0.2%) |
| July 23, 2026 | Increased |
NGNE — Neurogene Inc
64135M105
|
Units/share: 0.0003597 → 0.0003603 (0.1%) |
| July 23, 2026 | Trimmed |
THRD — Third Harmonic Bio Inc
88427A107
|
Units/share: 0.0006918 → 0.0006859 (-0.9%) |
| July 23, 2026 | Trimmed |
USD — CASH & EQUIVALENTS
CASHUSD00
|
Units/share: 0.003708 → 0.003683 (-0.7%) |
| July 23, 2026 | Trimmed |
— SECURITIES LENDING - BNYM
BNYMLEND
|
Units/share: 0.000000431 → 0.0000004274 (-0.9%) |
| July 21, 2026 | Trimmed |
2200963D — OmniAb Inc
68218J202
|
Units/share: 0.00005411 → 0.00005388 (-0.4%) |
| July 21, 2026 | Trimmed |
2200964D — OmniAb Inc
68218J301
|
Units/share: 0.00005411 → 0.00005388 (-0.4%) |
| July 21, 2026 | Trimmed |
2324462D — Cartesian Therapeutics Inc
816212112
|
Units/share: 0.00114 → 0.001135 (-0.4%) |
| July 21, 2026 | New |
2600057D — Novo Nordisk A/S
009CVR108
|
New position — 0.001635 units/share |
| July 21, 2026 | Trimmed |
2645588D — Eli Lilly & Co
152CVR015
|
Units/share: 0.002746 → 0.002734 (-0.4%) |
| July 21, 2026 | Trimmed |
2673120D — Esperion Therapeutics Inc
296CVR020
|
Units/share: 0.005725 → 0.0057 (-0.4%) |
| July 21, 2026 | Trimmed |
AGPXX — Invesco Government & Agency Portfolio
825252885
|
Units/share: 0.01933 → 0.01929 (-0.2%) |
| July 21, 2026 | Trimmed |
THRD — Third Harmonic Bio Inc
88427A107
|
Units/share: 0.0006948 → 0.0006918 (-0.4%) |
| July 21, 2026 | Trimmed |
USD — CASH & EQUIVALENTS
CASHUSD00
|
Units/share: 0.003724 → 0.003708 (-0.4%) |
| July 21, 2026 | Exited |
009CVR044
|
Position exited — was 0.001642 units/share |
| July 21, 2026 | Trimmed |
— SECURITIES LENDING - BNYM
BNYMLEND
|
Units/share: 0.0000004329 → 0.000000431 (-0.4%) |
| July 17, 2026 | New |
2200963D — OmniAb Inc
68218J202
|
New position — 0.00005411 units/share |
| July 17, 2026 | New |
2200964D — OmniAb Inc
68218J301
|
New position — 0.00005411 units/share |
| July 17, 2026 | New |
2324462D — Cartesian Therapeutics Inc
816212112
|
New position — 0.00114 units/share |
| July 17, 2026 | New |
2645588D — Eli Lilly & Co
152CVR015
|
New position — 0.002746 units/share |
| July 17, 2026 | New |
2673120D — Esperion Therapeutics Inc
296CVR020
|
New position — 0.005725 units/share |
| July 17, 2026 | New |
AARD — Aardvark Therapeutics Inc
002942100
|
New position — 0.0004957 units/share |
| July 17, 2026 | New |
ABCL — AbCellera Biologics Inc
00288U106
|
New position — 0.007012 units/share |
| July 17, 2026 | New |
ABSI — Absci Corp
00091E109
|
New position — 0.00358 units/share |
| July 17, 2026 | New |
ABUS — Arbutus Biopharma Corp
03879J100
|
New position — 0.004536 units/share |
| July 17, 2026 | New |
ABVX — Abivax SA
00370M103
|
New position — 0.001331 units/share |
| July 17, 2026 | New |
ACAD — ACADIA Pharmaceuticals Inc
004225108
|
New position — 0.003932 units/share |
| July 17, 2026 | New |
ACIU — AC Immune SA
H00263105
|
New position — 0.002313 units/share |
| July 17, 2026 | New |
ACRS — Aclaris Therapeutics Inc
00461U105
|
New position — 0.003207 units/share |
| July 17, 2026 | New |
ADMA — ADMA Biologics Inc
000899104
|
New position — 0.005322 units/share |
| July 17, 2026 | New |
ADPT — Adaptive Biotechnologies Corp
00650F109
|
New position — 0.003675 units/share |
| July 17, 2026 | New |
AGIO — Agios Pharmaceuticals Inc
00847X104
|
New position — 0.001366 units/share |
| July 17, 2026 | New |
AGPXX — Invesco Government & Agency Portfolio
825252885
|
New position — 0.01933 units/share |
| July 17, 2026 | New |
ALKS — Alkermes PLC
G01767105
|
New position — 0.003827 units/share |
| July 17, 2026 | New |
ALLO — Allogene Therapeutics Inc
019770106
|
New position — 0.007926 units/share |
| July 17, 2026 | New |
ALMS — Alumis Inc
022307102
|
New position — 0.002834 units/share |
| July 17, 2026 | New |
ALNY — Alnylam Pharmaceuticals Inc
02043Q107
|
New position — 0.003066 units/share |
| July 17, 2026 | New |
ALT — Altimmune Inc
02155H200
|
New position — 0.004466 units/share |
| July 17, 2026 | New |
ALVO — Alvotech SA
L01800108
|
New position — 0.007165 units/share |
| July 17, 2026 | New |
AMGN — Amgen Inc
031162100
|
New position — 0.007149 units/share |
| July 17, 2026 | New |
AMLX — Amylyx Pharmaceuticals Inc
03237H101
|
New position — 0.002553 units/share |
| July 17, 2026 | New |
AMPH — Amphastar Pharmaceuticals Inc
03209R103
|
New position — 0.001013 units/share |
| July 17, 2026 | New |
AMRX — Amneal Pharmaceuticals Inc
03168L105
|
New position — 0.007326 units/share |
| July 17, 2026 | New |
ANAB — AnaptysBio Inc
032724106
|
New position — 0.0006684 units/share |
| July 17, 2026 | New |
ANIP — ANI Pharmaceuticals Inc
00182C103
|
New position — 0.0005221 units/share |
| July 17, 2026 | New |
ANNX — Annexon Inc
03589W102
|
New position — 0.003762 units/share |
| July 17, 2026 | New |
APGE — Apogee Therapeutics Inc
03770N101
|
New position — 0.001422 units/share |
| July 17, 2026 | New |
AQST — Aquestive Therapeutics Inc
03843E104
|
New position — 0.002852 units/share |
| July 17, 2026 | New |
ARCT — Arcturus Therapeutics Holdings Inc
03969T109
|
New position — 0.000645 units/share |
| July 17, 2026 | New |
ARDX — Ardelyx Inc
039697107
|
New position — 0.005672 units/share |
| July 17, 2026 | New |
ARGX — Argenx SE
04016X101
|
New position — 0.0006338 units/share |
| July 17, 2026 | New |
ARQT — Arcutis Biotherapeutics Inc
03969K108
|
New position — 0.002872 units/share |
| July 17, 2026 | New |
ARVN — Arvinas Inc
04335A105
|
New position — 0.001467 units/share |
| July 17, 2026 | New |
ARWR — Arrowhead Pharmaceuticals Inc
04280A100
|
New position — 0.003235 units/share |
| July 17, 2026 | New |
ASND — Ascendis Pharma A/S
K08588103
|
New position — 0.001414 units/share |
| July 17, 2026 | New |
ATAI — AtaiBeckley Inc
04650F101
|
New position — 0.008454 units/share |
| July 17, 2026 | New |
AUPH — Aurinia Pharmaceuticals Inc
05156V102
|
New position — 0.002953 units/share |
| July 17, 2026 | New |
AURA — Aura Biosciences Inc
05153U107
|
New position — 0.002374 units/share |
| July 17, 2026 | New |
AUTL — Autolus Therapeutics PLC
05280R100
|
New position — 0.004561 units/share |
| July 17, 2026 | New |
AVBP — ArriVent Biopharma Inc
04272N102
|
New position — 0.001069 units/share |
| July 17, 2026 | New |
AVIR — Atea Pharmaceuticals Inc
04683R106
|
New position — 0.001819 units/share |
| July 17, 2026 | New |
AVXL — Anavex Life Sciences Corp
032797300
|
New position — 0.002106 units/share |
| July 17, 2026 | New |
AXSM — Axsome Therapeutics Inc
05464T104
|
New position — 0.001182 units/share |
| July 17, 2026 | New |
BBIO — Bridgebio Pharma Inc
10806X102
|
New position — 0.004497 units/share |
| July 17, 2026 | New |
BCAX — Bicara Therapeutics Inc
055477103
|
New position — 0.001509 units/share |
| July 17, 2026 | New |
BCRX — BioCryst Pharmaceuticals Inc
09058V103
|
New position — 0.005836 units/share |
| July 17, 2026 | New |
BCYC — Bicycle Therapeutics PLC
088786108
|
New position — 0.001061 units/share |
| July 17, 2026 | New |
BDTX — Black Diamond Therapeutics Inc
09203E105
|
New position — 0.001302 units/share |
| July 17, 2026 | New |
BEAM — Beam Therapeutics Inc
07373V105
|
New position — 0.002362 units/share |
| July 17, 2026 | New |
BIIB — Biogen Inc
09062X103
|
New position — 0.00339 units/share |
| July 17, 2026 | New |
BIOA — BioAge Labs Inc
09077V100
|
New position — 0.001021 units/share |
| July 17, 2026 | New |
BMRN — BioMarin Pharmaceutical Inc
09061G101
|
New position — 0.004438 units/share |
| July 17, 2026 | New |
BNTX — BioNTech SE
09075V102
|
New position — 0.002668 units/share |
| July 17, 2026 | New |
CABA — Cabaletta Bio Inc
12674W109
|
New position — 0.003706 units/share |
| July 17, 2026 | New |
CADL — Candel Therapeutics Inc
137404109
|
New position — 0.001683 units/share |
| July 17, 2026 | New |
CAI — Caris Life Sciences Inc
142152107
|
New position — 0.006491 units/share |
| July 17, 2026 | New |
CCCC — C4 Therapeutics Inc
12529R107
|
New position — 0.002513 units/share |
| July 17, 2026 | New |
CDXS — Codexis Inc
192005106
|
New position — 0.002067 units/share |
| July 17, 2026 | New |
CGEM — Cullinan Therapeutics Inc
230031106
|
New position — 0.001411 units/share |
| July 17, 2026 | New |
CGON — CG oncology Inc
156944100
|
New position — 0.002026 units/share |
| July 17, 2026 | New |
CHRS — Coherus Oncology Inc
19249H103
|
New position — 0.003506 units/share |
| July 17, 2026 | New |
CMPS — Compass Pathways Plc
20451W101
|
New position — 0.003056 units/share |
| July 17, 2026 | New |
COGT — Cogent Biosciences Inc
19240Q201
|
New position — 0.003923 units/share |
| July 17, 2026 | New |
COLL — Collegium Pharmaceutical Inc
19459J104
|
New position — 0.0007446 units/share |
| July 17, 2026 | New |
CRBU — Caribou Biosciences Inc
142038108
|
New position — 0.002255 units/share |
| July 17, 2026 | New |
CRMD — CorMedix Inc
21900C308
|
New position — 0.001801 units/share |
| July 17, 2026 | New |
CRNX — Crinetics Pharmaceuticals Inc
22663K107
|
New position — 0.002421 units/share |
| July 17, 2026 | New |
CRSP — CRISPR Therapeutics AG
H17182108
|
New position — 0.002215 units/share |
| July 17, 2026 | New |
CRVS — Corvus Pharmaceuticals Inc
221015100
|
New position — 0.001931 units/share |
| July 17, 2026 | New |
CSTL — Castle Biosciences Inc
14843C105
|
New position — 0.0006965 units/share |
| July 17, 2026 | New |
CTMX — CytomX Therapeutics Inc
23284F105
|
New position — 0.004999 units/share |
| July 17, 2026 | New |
CTNM — Contineum Therapeutics Inc
21217B100
|
New position — 0.0007515 units/share |
| July 17, 2026 | New |
CYTK — Cytokinetics Inc
23282W605
|
New position — 0.003113 units/share |
| July 17, 2026 | New |
DFTX — Definium Therapeutics Inc
24477V105
|
New position — 0.002504 units/share |
| July 17, 2026 | New |
DNLI — Denali Therapeutics Inc
24823R105
|
New position — 0.003645 units/share |
| July 17, 2026 | New |
DSGN — Design Therapeutics Inc
25056L103
|
New position — 0.001434 units/share |
| July 17, 2026 | New |
DYN — Dyne Therapeutics Inc
26818M108
|
New position — 0.003796 units/share |
| July 17, 2026 | New |
EDIT — Editas Medicine Inc
28106W103
|
New position — 0.003488 units/share |
| July 17, 2026 | New |
ELVN — Enliven Therapeutics Inc
29337E102
|
New position — 0.001399 units/share |
| July 17, 2026 | New |
ENTA — Enanta Pharmaceuticals Inc
29251M106
|
New position — 0.0006615 units/share |
| July 17, 2026 | New |
EOLS — Evolus Inc
30052C107
|
New position — 0.001497 units/share |
| July 17, 2026 | New |
ERAS — Erasca Inc
29479A108
|
New position — 0.007141 units/share |
| July 17, 2026 | New |
ETON — Eton Pharmaceuticals Inc
29772L108
|
New position — 0.000629 units/share |
| July 17, 2026 | New |
EWTX — Edgewise Therapeutics Inc
28036F105
|
New position — 0.002471 units/share |
| July 17, 2026 | New |
EXEL — Exelixis Inc
30161Q104
|
New position — 0.005772 units/share |
| July 17, 2026 | New |
EYPT — EyePoint Inc
30233G209
|
New position — 0.001925 units/share |
| July 17, 2026 | New |
FDMT — 4D Molecular Therapeutics Inc
35104E100
|
New position — 0.0012 units/share |
| July 17, 2026 | New |
FHTX — Foghorn Therapeutics Inc
344174107
|
New position — 0.001334 units/share |
Showing latest 200 of 367 changes
Institutional owners (13F) 37 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| RAYMOND JAMES FINANCIAL INC | $2,557,596 | 15.82% | 78,310 | Shares | June 30, 2026 |
| WMS Group LLC | $1,930,794 | 11.94% | 59,118 | Shares | June 30, 2026 |
| TWO SIGMA INVESTMENTS, LP | $1,678,724 | 10.38% | 51,400 | Shares | June 30, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,631,404 | 10.09% | 49,951 | Shares | June 30, 2026 |
| Independent Advisor Alliance | $969,232 | 5.99% | 29,676 | Shares | June 30, 2026 |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | $956,938 | 5.92% | 29,300 | Shares | June 30, 2026 |
| Advisory Services Network, LLC | $710,638 | 4.39% | 21,759 | Shares | June 30, 2026 |
| Churchill Financial Advisors, LLC | $663,847 | 4.11% | 20,326 | Shares | June 30, 2026 |
| Orion Porfolio Solutions, LLC | $646,333 | 4.00% | 19,790 | Shares | June 30, 2026 |
| Clearstead Advisors, LLC | $634,959 | 3.93% | 19,441 | Shares | June 30, 2026 |
| LPL Financial LLC | $521,254 | 3.22% | 15,960 | Shares | June 30, 2026 |
| Tower Research Capital LLC (TRC) | $496,236 | 3.07% | 15,194 | Shares | June 30, 2026 |
| Concurrent Investment Advisors, LLC | $463,849 | 2.87% | 14,202 | Shares | June 30, 2026 |
| Clarius Group, LLC | $407,512 | 2.52% | 19,231 | Shares | March 31, 2025 |
| Beckerman Institutional, LLC | $374,138 | 2.31% | 11,456 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $340,685 | 2.11% | 10,431 | Shares | June 30, 2026 |
| CreativeOne Wealth, LLC | $289,470 | 1.79% | 8,863 | Shares | June 30, 2026 |
| Ignite Planners, LLC | $260,267 | 1.61% | 7,954 | Shares | June 30, 2026 |
| Breakwater Capital Group | $230,678 | 1.43% | 7,063 | Shares | June 30, 2026 |
| Lauer Wealth, LLC | $201,252 | 1.24% | 6,200 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $43,000 | 0.27% | 1,306 | Shares | June 30, 2026 |
| ORG Partners LLC | $30,298 | 0.19% | 1,067 | Shares | Dec. 31, 2025 |
| Signature Equity Partners, LLC | $21,345 | 0.13% | 654 | Shares | June 30, 2026 |
| Princeton Global Asset Management LLC | $19,617 | 0.12% | 601 | Shares | June 30, 2026 |
| MORGAN STANLEY | $17,963 | 0.11% | 550 | Shares | June 30, 2026 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $16,330 | 0.10% | 500 | Shares | June 30, 2026 |
| WR Wealth Planners, LLC | $14,741 | 0.09% | 685 | Shares | Dec. 31, 2024 |
| FMR LLC | $8,590 | 0.05% | 263 | Shares | June 30, 2026 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $8,197 | 0.05% | 251 | Shares | June 30, 2026 |
| PRIVATE TRUST CO NA | $7,414 | 0.05% | 227 | Shares | June 30, 2026 |
| HARBOUR INVESTMENTS, INC. | $5,467 | 0.03% | 167 | Shares | June 30, 2026 |
| Strengthening Families & Communities, LLC | $3,218 | 0.02% | 99 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $2,776 | 0.02% | 85 | Shares | June 30, 2026 |
| Institute for Wealth Management, LLC. | $2,515 | 0.02% | 77 | Shares | June 30, 2026 |
| AE Wealth Management LLC | $2,188 | 0.01% | 67 | Shares | June 30, 2026 |
| Meramec Financial Planners, LLC | $815 | 0.01% | 25 | Shares | June 30, 2026 |
| Farmers & Merchants Trust Co of Chambersburg PA | $7 | 0.00% | 200 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| QQQ Invesco QQQ Trust, Series 1 | $496.1B |
| QQQM Invesco Exchange-Traded Fund Tr… | $97.2B |
| RSP Invesco Exchange-Traded Fund Tr… | $87.9B |
| SPMO Invesco Exchange-Traded Fund Tr… | $19.9B |
| SPHQ Invesco Exchange-Traded Fund Tr… | $17.3B |
| PBUS Invesco Exchange-Traded Fund Tr… | $11.5B |
| XLG Invesco Exchange-Traded Fund Tr… | $10.7B |
| PRF Invesco Exchange-Traded Fund Tr… | $9.5B |
| RWL Invesco Exchange-Traded Fund Tr… | $9.1B |
| PPA Invesco Exchange-Traded Fund Tr… | $8.0B |
Similar by size
| Fund | AUM |
|---|---|
| WDTE Tidal Trust II | $67.5M |
| FMCE Northern Lights Fund Trust IV | $67.5M |
| SXQG EXCHANGE TRADED CONCEPTS TRUST | $67.6M |
| POW Tidal Trust III | $67.6M |
| ITDF iShares Trust | $67.7M |
| RSDE First Trust Exchange-Traded Fun… | $67.0M |
| EMC Global X Funds | $66.8M |
| SJB ProShares Trust | $66.5M |
| MARO Tidal Trust II | $66.2M |
| QCJL First Trust Exchange-Traded Fun… | $66.1M |